Related Experiment Video
Updated: Jun 28, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Preeclampsia and risk for epilepsy in offspring
Chun Sen Wu1, Yuelian Sun, Mogens Vestergaard
1Department of Epidemiology, Institute of Public Health, University of Aarhus, Aarhus, Denmark. cw@soci.au.dk
Pediatrics
|November 4, 2008
Summary
Prenatal exposure to preeclampsia and eclampsia increases epilepsy risk in children born at term or postterm. This risk is higher for severe preeclampsia and eclampsia, particularly in postterm births.
Area of Science:
- Obstetrics and Gynecology
- Pediatric Neurology
- Epidemiology
Background:
- Eclampsia is a known risk factor for childhood epilepsy.
- The association between preeclampsia and offspring epilepsy risk remains unclear.
Purpose of the Study:
- To investigate the association between prenatal exposure to preeclampsia and eclampsia and the risk of epilepsy in offspring.
- To determine if the risk of epilepsy differs based on the severity of preeclampsia and gestational age at birth.
Main Methods:
- Population-based cohort study of 1,537,860 singletons born in Denmark (1978-2004).
- Utilized Danish National Hospital Register and Danish Medical Birth Registry for data on preeclampsia, eclampsia, epilepsy, and birth characteristics.
- Employed Cox proportional hazard models to estimate incidence rate ratios for epilepsy following prenatal exposure.
Main Results:
- Prenatal preeclampsia exposure was linked to increased epilepsy risk in children born at or after 37 weeks gestation.
- Incidence rate ratios for epilepsy increased with preeclampsia severity and postterm birth.
- Eclampsia exposure also showed an increased epilepsy risk, especially in postterm births.
Conclusions:
- Prenatal exposure to preeclampsia and eclampsia is associated with a higher risk of epilepsy in children born after 37 weeks gestation.
- The findings highlight the importance of monitoring children exposed to hypertensive disorders of pregnancy for neurological development.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...